The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020

– The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”),a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that 56 white label and custom manufacturing product SKUs were produced in the third quarter of 2020, a 56% increase from 36 SKUs in the second quarter of 2020.Continue reading “The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020”

Shoppers Drug Mart to expand Canadians’ access to virtual care through $75 million investment in Maple

– (TSX: L): Loblaw Companies Ltd (“Loblaw” or the “Company”) has taken a significant step forward on its journey to provide Canadians with the convenience and security of a digitally connected healthcare network. Today, the Company announced that its wholly owned subsidiary Shoppers Drug Mart Inc. (“Shoppers Drug Mart”) will invest $75 million in Maple Corporation (“Maple”), the leading virtualContinue reading “Shoppers Drug Mart to expand Canadians’ access to virtual care through $75 million investment in Maple”

MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm Peru

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply premium, formulated cannabis oil to Cann Farm Peru S.A.C., a Lima-based producer and distributor serving Peruvian and other markets inContinue reading “MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm Peru”

Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany

 — Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) indirect subsidiary, Aleafia Health Germany GmbH (“Aleafia Germany”) will commence distributing medical cannabis products to German pharmacies following regulatory approvals. Aleafia Germany has now received a controlled drug licence from the Federal Institute for Drugs and Medical Devices and a European UnionContinue reading “Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany”

Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

 – September 1, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) reported financial results for the three and six months ended June 30, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com. “The second quarter was a very solid quarter in allContinue reading “Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update”

Curaleaf Opens its First Retail Location in Utah with Lehi Pharmacy

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announced the company’s first retail location in the Utah market with a new pharmacy at 3633 N. Thanksgiving Way in Lehi, marking its 90th retail location nationwide. Curaleaf UT, LLC, was awarded one of the state’s 14 licenses in theContinue reading “Curaleaf Opens its First Retail Location in Utah with Lehi Pharmacy”

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update

Revenue continues to accelerate. The Company generated $1.2 million in revenue during Q2-2020, reaching $1.7 Million YTD 2020 compared to $786,901 in its full 2019 fiscal year. Recent increase in active cultivation footprint readies PharmaCielo to process and deliver more extracted product during the second half of 2020 and into 2021. Production from the Company’s Processing and Extraction Centre will beginContinue reading “PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update”

Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects

SYNC(TM) Nano Fast Action Spray uses nanoemulsion technology to enable rapid onset and shorter duration of effects; the first THC product is in-market, with CBD to follow  –  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”)  has launched the first product in its adult-use SYNCTM Nano fast-acting cannabis spray product line. SYNCTM 15 Nano THC FastContinue reading “Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects”

Canada House Wellness Group Reports Fiscal Year 2020 Results

 -Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company“) is pleased to report its financial results for the year ending April 30, 2020. All amounts are stated in thousands of Canadian dollars. Complete details may be found at www.sedar.com. Compared to the 12 months ending April 30, 2019: Revenue was $5,310, an increase of $435 or 9%, comparedContinue reading “Canada House Wellness Group Reports Fiscal Year 2020 Results”